Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Get the answer in writing
Ozempic (Injection) Indication : Type 2 Diabetes, cardiovascular risk reduction Frequency : Weekly Wegovy (Injection) Indication : Chronic weight management (obesity or overweight with comorbidities) Frequency : Weekly Rybelsus (Tablet) Indication : Type 2 Diabetes
Survodutide: Dual GLP-1 and glucagon receptor agonist Produced by the German company Boehringer Ingelheim, alongside Zealand Pharma, Survodutide is an injectable drug that activates both the glucagon and GLP-1 receptors
Looking Ahead GLP-1 drugs have revolutionized treatment for obesity, but recent regulatory activity is a reminder that existing rules apply even when the innovation is revolutionary
Incretin A category of hormones released from the gut that enhance insulin secretion after eating
A Selective Glutathione Probe based on AIE Fluorogen and its Application in Enzymatic Activity Assay
US$ 21.24
US$ 24.20
US$ 29.37
US$ 21.30
US$ 23.19
